Search Results
Results found for "GPCR research community"
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
GPCR ecosystem members! GPCR ecosystem. Top candidates will have a solid foundation in GPCR pharmacology as well as some experience in drug discovery GPCR
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
significant attention in drug discovery, especially in the context of G protein-coupled receptors (GPCRs The GLP-1R, a class B1 GPCR, is integral to metabolic regulation, particularly in glucose homeostasis Research by Prof. Nat Commun, 2015. 6 : p. 8918. 7. Cary, B.P., et al., New Insights into the Structure and Function of Class B1 GPCRs.
- 4GPCRnet - International Symposium
SEPTEMBER 26-29, 2022 (Leipzig, Germany) 4GPCRnet meeting bringing together four of the biggest GPCR Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded
- Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...
Neuropeptides and their specific receptors (primarily G protein-coupled receptors, GPCRs) regulate multiple A total of 41 neuropeptide GPCR genes belonging to three classes were also identified. These GPCRs and their probable ligands were predicted. expression patterns of these 98 genes in various larval tissues were evaluated using quantitative real-time PCR to determine physiological functions and pharmacological characterization of neuropeptides and their GPCRs
- Do You Believe AI Could Accelerate Drug Discovery?
G protein-coupled receptors (GPCRs) are major drug targets, yet their complex and dynamic structures By using machine learning, AF2 can accurately predict the 3D structures of GPCRs with atomic-level accuracy screening and large-scale data analysis, paving the way for a new era in precision medicine and medical research
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
By systematically mutating every amino acid in the protein and assessing the resulting phenotype, researchers residues spans from the extracellular surface to the transmembrane area, linking with canonical class A GPCR activation motifs to initiate proton-sensing GPCRs. By examining how mutations in the target protein affect its interaction with the drug, researchers can resources, including time, financial investment, and specialised expertise, limiting accessibility for some research
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
In complex organisms, cell to cell communication occurs mostly through neurotransmitters and hormones The G protein-coupled receptors (GPCRs) are the largest family of membrane receptors, with nearly 800 The recognition that GPCRs may physically interact with each other has led to the hypothesis that their Furthermore, the formation of GPCRs higher order oligomers provides the structural basis for organizing
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
all cytomegalovirus (CMV) genomes analysed to date is the presence of G protein-coupled receptors (GPCR IMPORTANCE G protein-coupled receptors (GPCRs) act as cell surface molecular "switches" which regulate All cytomegalovirus (CMV) genomes analysed to date possess GPCR homologs with phylogenetic evidence for The mouse CMV (MCMV) GPCR homolog, designated M33, is important for cell-associated virus spread and The signalling repertoire of M33 is distinct from cellular GPCRs and little is known of the relevance
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
bilayer creates is dynamic and interactive, becoming the foundation for many interactions involved in GPCR activation of GPCRs2. β-arrestins are cytosolic proteins that translocate to the plasma membrane upon GPCR Understanding the interplay between GPCRs and β-arrestins and how this complex operates on the plasma Membrane phosphoinositides regulate GPCR-β-arrestin complex assembly and dynamics. Molecular mechanism of GPCR-mediated arrestin activation.
- Phospholipid Scrambling by G Protein-Coupled Receptors
Unexpectedly, Class A G protein-coupled receptors (GPCRs), a large class of signaling proteins exemplified transbilayer lipid movement, conceptualized as the swiping of a credit card (lipid) through a card reader (GPCR Conformational changes that facilitate scrambling are distinct from those associated with GPCR signaling In this review, we discuss the physiological significance of GPCR scramblase activity and the modes of
- TLR4 biased small molecule modulators
Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors (GPCRs The biased signaling modulation of non-GPCR receptors has yet to be exploited. Toll-like receptor 4 (TLR4) is one such non-GPCR receptor, which involves MyD88-dependent and TRIF-dependent modulators of TLR4 would provide insight for the future development of biased modulators for other non-GPCR
- Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...
this study was to identify Gα proteins mediating function of neuronal G protein-coupled receptors (GPCRs Some neuronal GPCRs (such as GTR-1, DCAR-1, DOP-2, NPR-8, NPR-12, NPR-9, and DAF-37) functioned upstream of GOA-1, some neuronal GPCRs (such as DCAR-1, DOP-2, NPR-9, NPR-8, and DAF-37) functioned upstream of GSA-1, and some neuronal GPCRs (such as DOP-2, NPR-8, DAF-37, and DCAR-1) functioned upstream of GPA Our results provide clues for understanding the important function of GPCRs-Gα signaling cascade in the
- Precise druggability of the PTH type 1 receptor
Class B G protein-coupled receptors (GPCRs) are notoriously difficult to target by small molecules because Using the parathyroid hormone type 1 receptor (PTHR) as a prototypic class B GPCR target, and a combination precise druggable sites and identify allosteric modulators of PTHR signaling that could be extended to GPCRs
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
allosteric binding site (IABS) has recently been identified at several G protein-coupled receptors (GPCRs To chemically induce CCR9 degradation, we then developed the first PROTAC targeting the IABS of GPCRs our CCR9-PROTAC is able to reduce CCR9 levels, thereby offering an unprecedented approach to modulate GPCR
- The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...
molecular recognition of two peptidyl mating pheromones by their corresponding G-protein coupled receptors (GPCRs Here, we investigated the stringency of the two GPCRs, Mam2 and Map3, for their respective pheromones First, we switched GPCRs between S. pombe and the closely related species Schizosaccharomyces octosporus Thus, the differences in these two GPCRs might reflect the significantly distinct stringency/flexibility
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
regulate a wide range of signaling events, most notably when bound to active G protein-coupled receptors (GPCRs Among the known effectors recruited by GPCR-bound arrestins are Src family kinases, which regulate cellular determined the crystal structure of the Fgr SH3 domain at 1.9 Å resolution and developed a model for the GPCR-arrestin
- G protein-coupled receptor kinase 2 is essential to enable vasoconstrictor-mediated arterial ...
vasoconstrictors, resulting in enhanced signalling through their cognate G protein-coupled receptors (GPCR Prolonged vasoconstrictor GPCR signalling increases arterial contraction and stimulates signalling pathways GPCR signalling through phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) promotes VSMC proliferation In VSMC, G protein-coupled receptor kinase 2 (GRK2) is known to regulate numerous vasoconstrictor GPCRs
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
Alterations in the expression and/or activity of brain G-protein-coupled receptors (GPCRs) such as dopamine Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition Functional GPCR assays unfolded the compound's antagonist behavior on D1R (IC50 42.1 ± 0.35 μM) and agonist
- Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage...
Several neurotransmitters and neuromodulators, acting through G-protein-coupled receptors (GPCRs), fine-tune However, intracellular partners linking GPCRs to TASK1 modulation are not yet well-known. We hypothesized that isoform 2 of rho-kinase (ROCK2), acting as downstream GPCRs, mediates adjustment Furthermore, ROCK activity assays were performed to evaluate the ability of various physiological GPCR
- Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs
Opioid receptors are G-protein-coupled receptors (GPCRs) part of cell signaling paths of direct interest typically have a protonated amino group that contributes to receptor binding, and the functioning of GPCRs
- Chemokine receptor-targeted drug discovery: progress and challenges
the notion that redundancy is not a feature of the chemokine system (Nedjai et al. 2012), but more research Further difficulties arise from the existence of cross-reactivity with other GPCRs and differences in of chemokine receptors which are regulated by globular protein ligands, unlike most of the class A GPCRs
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Mutations in G protein-coupled receptors (GPCRs) underlie numerous diseases. Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the These findings aid in advancing the understanding of the effects of genetic mutations on GPCR function
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and modulates Dynamic network analysis further reveals that Nb80 binding triggers tighter and stronger local communication Altogether, our results provide insights into the effect of intracellular binding partners on the GPCR
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
Despite intensive research, a known treatment for MS disease yet to be introduced. their functional activities are achieved by binding to the cell surface G protein-coupled receptors (GPCRs
- HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural ...
multiple immune signaling processes and is dependent on activation by Ras and G protein-coupled receptors (GPCRs that stimulated lipid kinase activity, block Ras activation, and specifically inhibited p101-mediated GPCR
- Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation
Engineered G protein-coupled receptors (GPCRs) are commonly used in chemogenetics as designer receptors Although several GPCRs have been studied in astrocytes using a chemogenetic approach, the functional
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
is a key protein that mediates desensitization and internalization of G protein-coupled receptors (GPCRs This research further clarified the underlying role of β-arrestin2 and provided an experimental foundation
- Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle
Numerous physiological effects of melatonin are mediated via its specific G protein-coupled receptors (GPCRs human and guinea pig airway smooth muscle and cultured human airway smooth muscle (HASM) cells by RT-PCR
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
target for control of the fall webworm Hyphantria cunea Background: Insect G protein-coupled receptors (GPCRs HLGR2 is a typical GPCR and shows high structural and sequence similarity with other insect LGR2 proteins
- A role for BET proteins in regulating basal, dopamine-induced and cAMP/PKA-dependent ...
The D1 receptor (D1R) is a Gαs/olf-coupled GPCR which activates a cAMP/PKA/DARPP-32 signalling cascade Finally, we report that JQ1 treatment downregulated expression of many GPCRs and also impaired ERK1/2


